Floatz logo

Therapeutic Asset Ratings

766 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
177lu-dtpa-sc16.56
Neuroendocrine Carcinoma
Memorial Sloan Kettering Cancer CenterP1CC (41)
18f-trx
Malignant Glioma
Rahul AggarwalP1CC (41)
18f-trx
Carcinoma
Rahul AggarwalP1CC (41)
[212pb]vmt-alpha-net
Nasopharyngeal Carcinoma
National Cancer Institute (NCI)P1CC (41)
[225Ac]Ac-AKY-1189
Bladder Transitional Cell Carcinoma
Aktis Oncology, Inc.P1CC (41)
225ac-etn029
Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1CC (41)
[225]-fpi-2059
Ewing Sarcoma
3B Pharmaceuticals GmbHP1CC (41)
[225]-fpi-2059
Head And Neck Squamous Cell Carcinoma
3B Pharmaceuticals GmbHP1CC (41)
4.7 microci 225ac-mti-201
Uveal Melanoma
Modulation Therapeutics, Inc.P1CC (41)
64cu-grip b
Non-Hodgkin Lymphoma
Michael RandallP1CC (41)
89-zr-dfo-star polyethylene glycol
Carcinoma
Robert Flavell, MD, PhDP1CC (41)
998 microci of 225ac-mti-201
Uveal Melanoma
Modulation Therapeutics, Inc.P1CC (41)
Actinium-J591
Metastatic Prostate Carcinoma
Weill Medical College of Cornell UniversityP1CC (41)
Copper Cu 64-Dota-A2Dm
Pancreatic Adenocarcinoma
City of Hope Medical CenterP1CC (41)
Indium In 111-Dota-Basiliximab
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical CenterP1CC (41)
[Lu-177]-Pnt6555
Cutaneous Melanoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1CC (41)
[Lu-177]-Pnt6555
Soft Tissue Sarcoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1CC (41)
rad301
Healthy Volunteers
Radiopharm Theranostics, LtdP1CC (41)
Zirconium Zr 89-Dfo-Ys5
Carcinoma
Robert Flavell, MD, PhDP1CC (41)
Copper Cu-64-Dota-Alendronate
Breast Carcinoma
City of Hope Medical CenterEarly P1CC (41)
[111in]-fpi-1967
Gastric Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
[111in]-fpi-1967
Head And Neck Squamous Cell Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (41)
[111in]-fpi-1967
Liver Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
[111in]-fpi-1967
Lung Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
161Tb-NYM032
Cancer
Zhengguo ChenP1/2CC (41)
Showing 326 to 350 of 766 assets
PreviousPage 14 of 31Next